Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,330,298
+$673,900 QoQ
Shares Held
80,050
-0.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#731
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GAMCO INVESTORS, INC. ET AL holds $86,182,010 across 9 Drug Manufacturers - General names. JNJ ranks #2 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,377 | $32,836,797 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
80,050 | $20,330,298 | |
| 3 | PFE |
Pfizer Inc
|
571,286 | $13,756,566 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,672 | $8,053,352 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
82,671 | $4,763,503 | |
| 6 | ABBV |
AbbVie Inc.
|
13,603 | $3,423,058 | |
| 7 | AMGN |
Amgen Inc
|
4,618 | $1,672,270 | |
| 8 | OGN |
Organon & Co.
|
86,872 | $1,176,246 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,330,298 | 80,050 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $19,656,398 | 80,414 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,921,473 | 81,766 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $15,273,972 | 82,375 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,225,400 | 86,582 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,380,649 | 86,714 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,440,115 | 92,934 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,651,916 | 96,581 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,376,589 | 98,362 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $16,525,001 | 104,463 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $16,950,177 | 108,142 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $17,677,002 | 113,496 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $22,028,063 | 133,084 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $21,898,865 | 141,283 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $27,541,148 | 155,908 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $25,345,467 | 155,151 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,415,435 | 137,544 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $17,252,099 | 97,343 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $17,415,439 | 101,803 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,586,050 | 102,700 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $17,314,668 | 105,103 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $18,028,537 | 109,696 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $18,204,144 | 115,670 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $17,704,809 | 118,920 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $17,353,038 | 123,395 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $17,507,559 | 133,513 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||